nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP2C9—Rosuvastatin—atherosclerosis	0.104	0.267	CbGbCtD
Agomelatine—CYP2C9—Simvastatin—atherosclerosis	0.0969	0.248	CbGbCtD
Agomelatine—CYP2C9—Lovastatin—atherosclerosis	0.0948	0.243	CbGbCtD
Agomelatine—CYP2C9—Pravastatin—atherosclerosis	0.0948	0.243	CbGbCtD
Agomelatine—Nightmare—Rosuvastatin—atherosclerosis	0.00525	0.016	CcSEcCtD
Agomelatine—Indomethacin—PLA2G2A—atherosclerosis	0.00472	0.28	CrCbGaD
Agomelatine—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.00461	0.014	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.00452	0.0137	CcSEcCtD
Agomelatine—Hepatic failure—Rosuvastatin—atherosclerosis	0.00439	0.0133	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.00431	0.0131	CcSEcCtD
Agomelatine—Nightmare—Simvastatin—atherosclerosis	0.00416	0.0126	CcSEcCtD
Agomelatine—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.0039	0.0118	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.00385	0.0117	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.00377	0.0115	CcSEcCtD
Agomelatine—Nightmare—Pravastatin—atherosclerosis	0.00376	0.0114	CcSEcCtD
Agomelatine—Hepatic failure—Lovastatin—atherosclerosis	0.00372	0.0113	CcSEcCtD
Agomelatine—Hepatic failure—Ezetimibe—atherosclerosis	0.00365	0.0111	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.0036	0.0109	CcSEcCtD
Agomelatine—Hepatic failure—Simvastatin—atherosclerosis	0.00348	0.0106	CcSEcCtD
Agomelatine—Eczema—Simvastatin—atherosclerosis	0.00348	0.0106	CcSEcCtD
Agomelatine—Influenza—Rosuvastatin—atherosclerosis	0.00341	0.0104	CcSEcCtD
Agomelatine—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.00325	0.00988	CcSEcCtD
Agomelatine—Eczema—Niacin—atherosclerosis	0.0032	0.00971	CcSEcCtD
Agomelatine—Hepatic failure—Pravastatin—atherosclerosis	0.00315	0.00956	CcSEcCtD
Agomelatine—Depression—Rosuvastatin—atherosclerosis	0.00303	0.00922	CcSEcCtD
Agomelatine—Jaundice—Rosuvastatin—atherosclerosis	0.00297	0.00901	CcSEcCtD
Agomelatine—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00293	0.00891	CcSEcCtD
Agomelatine—Nabumetone—MPO—atherosclerosis	0.00291	0.172	CrCbGaD
Agomelatine—Influenza—Lovastatin—atherosclerosis	0.00289	0.00878	CcSEcCtD
Agomelatine—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00288	0.00874	CcSEcCtD
Agomelatine—Influenza—Ezetimibe—atherosclerosis	0.00284	0.00862	CcSEcCtD
Agomelatine—Migraine—Niacin—atherosclerosis	0.00283	0.00859	CcSEcCtD
Agomelatine—Face oedema—Niacin—atherosclerosis	0.00277	0.00843	CcSEcCtD
Agomelatine—Hepatitis—Rosuvastatin—atherosclerosis	0.00273	0.0083	CcSEcCtD
Agomelatine—Nasopharyngitis—Pravastatin—atherosclerosis	0.00253	0.00769	CcSEcCtD
Agomelatine—Infestation NOS—Ezetimibe—atherosclerosis	0.00253	0.00768	CcSEcCtD
Agomelatine—Infestation—Ezetimibe—atherosclerosis	0.00253	0.00768	CcSEcCtD
Agomelatine—Influenza—Niacin—atherosclerosis	0.00248	0.00754	CcSEcCtD
Agomelatine—Jaundice—Ezetimibe—atherosclerosis	0.00247	0.00749	CcSEcCtD
Agomelatine—Influenza—Pravastatin—atherosclerosis	0.00245	0.00743	CcSEcCtD
Agomelatine—Depression—Simvastatin—atherosclerosis	0.0024	0.0073	CcSEcCtD
Agomelatine—Mental disorder—Rosuvastatin—atherosclerosis	0.00239	0.00727	CcSEcCtD
Agomelatine—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00239	0.00727	CcSEcCtD
Agomelatine—Jaundice—Simvastatin—atherosclerosis	0.00235	0.00714	CcSEcCtD
Agomelatine—Hepatitis—Lovastatin—atherosclerosis	0.00231	0.00703	CcSEcCtD
Agomelatine—Hepatitis—Ezetimibe—atherosclerosis	0.00227	0.0069	CcSEcCtD
Agomelatine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00223	0.00678	CcSEcCtD
Agomelatine—Weight increased—Pravastatin—atherosclerosis	0.00223	0.00676	CcSEcCtD
Agomelatine—Weight decreased—Pravastatin—atherosclerosis	0.00221	0.00672	CcSEcCtD
Agomelatine—Depression—Pravastatin—atherosclerosis	0.00217	0.0066	CcSEcCtD
Agomelatine—Angioedema—Rosuvastatin—atherosclerosis	0.00217	0.0066	CcSEcCtD
Agomelatine—Hepatitis—Simvastatin—atherosclerosis	0.00217	0.00658	CcSEcCtD
Agomelatine—Jaundice—Niacin—atherosclerosis	0.00216	0.00656	CcSEcCtD
Agomelatine—Jaundice—Pravastatin—atherosclerosis	0.00213	0.00646	CcSEcCtD
Agomelatine—Indomethacin—PPARA—atherosclerosis	0.00202	0.12	CrCbGaD
Agomelatine—Mental disorder—Ezetimibe—atherosclerosis	0.00199	0.00604	CcSEcCtD
Agomelatine—Hepatitis—Niacin—atherosclerosis	0.00199	0.00604	CcSEcCtD
Agomelatine—Hepatitis—Pravastatin—atherosclerosis	0.00196	0.00595	CcSEcCtD
Agomelatine—Back pain—Lovastatin—atherosclerosis	0.00195	0.00592	CcSEcCtD
Agomelatine—Infection—Rosuvastatin—atherosclerosis	0.00193	0.00586	CcSEcCtD
Agomelatine—Back pain—Ezetimibe—atherosclerosis	0.00191	0.00581	CcSEcCtD
Agomelatine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.0019	0.00578	CcSEcCtD
Agomelatine—Vision blurred—Lovastatin—atherosclerosis	0.0019	0.00577	CcSEcCtD
Agomelatine—Mental disorder—Simvastatin—atherosclerosis	0.0019	0.00576	CcSEcCtD
Agomelatine—Tremor—Lovastatin—atherosclerosis	0.00189	0.00573	CcSEcCtD
Agomelatine—Eye disorder—Niacin—atherosclerosis	0.00186	0.00564	CcSEcCtD
Agomelatine—Tinnitus—Niacin—atherosclerosis	0.00185	0.00563	CcSEcCtD
Agomelatine—Angioedema—Lovastatin—atherosclerosis	0.00184	0.00559	CcSEcCtD
Agomelatine—Tinnitus—Pravastatin—atherosclerosis	0.00183	0.00554	CcSEcCtD
Agomelatine—Vertigo—Lovastatin—atherosclerosis	0.00181	0.0055	CcSEcCtD
Agomelatine—Angioedema—Ezetimibe—atherosclerosis	0.00181	0.00549	CcSEcCtD
Agomelatine—Vision blurred—Simvastatin—atherosclerosis	0.00178	0.0054	CcSEcCtD
Agomelatine—Tremor—Simvastatin—atherosclerosis	0.00177	0.00536	CcSEcCtD
Agomelatine—Insomnia—Rosuvastatin—atherosclerosis	0.00176	0.00533	CcSEcCtD
Agomelatine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00174	0.00529	CcSEcCtD
Agomelatine—Angioedema—Simvastatin—atherosclerosis	0.00172	0.00523	CcSEcCtD
Agomelatine—Anxiety—Lovastatin—atherosclerosis	0.00171	0.00519	CcSEcCtD
Agomelatine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00171	0.00519	CcSEcCtD
Agomelatine—Vertigo—Simvastatin—atherosclerosis	0.00169	0.00514	CcSEcCtD
Agomelatine—Dry mouth—Lovastatin—atherosclerosis	0.00168	0.0051	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00167	0.00508	CcSEcCtD
Agomelatine—Constipation—Rosuvastatin—atherosclerosis	0.00166	0.00504	CcSEcCtD
Agomelatine—Dry mouth—Ezetimibe—atherosclerosis	0.00165	0.005	CcSEcCtD
Agomelatine—Infection—Lovastatin—atherosclerosis	0.00163	0.00496	CcSEcCtD
Agomelatine—Vision blurred—Niacin—atherosclerosis	0.00163	0.00495	CcSEcCtD
Agomelatine—Vision blurred—Pravastatin—atherosclerosis	0.00161	0.00488	CcSEcCtD
Agomelatine—Infection—Ezetimibe—atherosclerosis	0.0016	0.00487	CcSEcCtD
Agomelatine—Anxiety—Simvastatin—atherosclerosis	0.0016	0.00486	CcSEcCtD
Agomelatine—Tremor—Pravastatin—atherosclerosis	0.0016	0.00485	CcSEcCtD
Agomelatine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00159	0.00482	CcSEcCtD
Agomelatine—Nervous system disorder—Ezetimibe—atherosclerosis	0.00158	0.0048	CcSEcCtD
Agomelatine—Angioedema—Niacin—atherosclerosis	0.00158	0.0048	CcSEcCtD
Agomelatine—Skin disorder—Ezetimibe—atherosclerosis	0.00157	0.00476	CcSEcCtD
Agomelatine—Angioedema—Pravastatin—atherosclerosis	0.00156	0.00473	CcSEcCtD
Agomelatine—Vertigo—Niacin—atherosclerosis	0.00155	0.00472	CcSEcCtD
Agomelatine—Urticaria—Rosuvastatin—atherosclerosis	0.00154	0.00468	CcSEcCtD
Agomelatine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00153	0.00466	CcSEcCtD
Agomelatine—Vertigo—Pravastatin—atherosclerosis	0.00153	0.00465	CcSEcCtD
Agomelatine—Infection—Simvastatin—atherosclerosis	0.00153	0.00464	CcSEcCtD
Agomelatine—Insomnia—Lovastatin—atherosclerosis	0.00149	0.00452	CcSEcCtD
Agomelatine—Paraesthesia—Lovastatin—atherosclerosis	0.00148	0.00449	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00146	0.00444	CcSEcCtD
Agomelatine—Insomnia—Ezetimibe—atherosclerosis	0.00146	0.00443	CcSEcCtD
Agomelatine—Paraesthesia—Ezetimibe—atherosclerosis	0.00145	0.0044	CcSEcCtD
Agomelatine—Dyspepsia—Lovastatin—atherosclerosis	0.00145	0.0044	CcSEcCtD
Agomelatine—Anxiety—Pravastatin—atherosclerosis	0.00145	0.00439	CcSEcCtD
Agomelatine—Dry mouth—Niacin—atherosclerosis	0.00144	0.00438	CcSEcCtD
Agomelatine—Dyspepsia—Ezetimibe—atherosclerosis	0.00142	0.00431	CcSEcCtD
Agomelatine—Fatigue—Lovastatin—atherosclerosis	0.00142	0.00431	CcSEcCtD
Agomelatine—Constipation—Lovastatin—atherosclerosis	0.00141	0.00427	CcSEcCtD
Agomelatine—Indomethacin—CXCL8—atherosclerosis	0.0014	0.0831	CrCbGaD
Agomelatine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00139	0.00423	CcSEcCtD
Agomelatine—Asthenia—Rosuvastatin—atherosclerosis	0.00139	0.00423	CcSEcCtD
Agomelatine—Insomnia—Simvastatin—atherosclerosis	0.00139	0.00423	CcSEcCtD
Agomelatine—Fatigue—Ezetimibe—atherosclerosis	0.00139	0.00422	CcSEcCtD
Agomelatine—Infection—Pravastatin—atherosclerosis	0.00138	0.0042	CcSEcCtD
Agomelatine—Paraesthesia—Simvastatin—atherosclerosis	0.00138	0.0042	CcSEcCtD
Agomelatine—Constipation—Ezetimibe—atherosclerosis	0.00138	0.00419	CcSEcCtD
Agomelatine—Pruritus—Rosuvastatin—atherosclerosis	0.00137	0.00417	CcSEcCtD
Agomelatine—Skin disorder—Niacin—atherosclerosis	0.00137	0.00417	CcSEcCtD
Agomelatine—Hyperhidrosis—Niacin—atherosclerosis	0.00137	0.00415	CcSEcCtD
Agomelatine—Dyspepsia—Simvastatin—atherosclerosis	0.00135	0.00411	CcSEcCtD
Agomelatine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00134	0.00408	CcSEcCtD
Agomelatine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00134	0.00408	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00133	0.00403	CcSEcCtD
Agomelatine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00133	0.00403	CcSEcCtD
Agomelatine—Fatigue—Simvastatin—atherosclerosis	0.00133	0.00403	CcSEcCtD
Agomelatine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00132	0.00401	CcSEcCtD
Agomelatine—Constipation—Simvastatin—atherosclerosis	0.00132	0.004	CcSEcCtD
Agomelatine—Urticaria—Lovastatin—atherosclerosis	0.00131	0.00397	CcSEcCtD
Agomelatine—Abdominal pain—Lovastatin—atherosclerosis	0.0013	0.00395	CcSEcCtD
Agomelatine—Dizziness—Rosuvastatin—atherosclerosis	0.00128	0.0039	CcSEcCtD
Agomelatine—Urticaria—Ezetimibe—atherosclerosis	0.00128	0.00389	CcSEcCtD
Agomelatine—Insomnia—Niacin—atherosclerosis	0.00128	0.00388	CcSEcCtD
Agomelatine—Abdominal pain—Ezetimibe—atherosclerosis	0.00128	0.00387	CcSEcCtD
Agomelatine—Paraesthesia—Niacin—atherosclerosis	0.00127	0.00385	CcSEcCtD
Agomelatine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00126	0.00382	CcSEcCtD
Agomelatine—Insomnia—Pravastatin—atherosclerosis	0.00126	0.00382	CcSEcCtD
Agomelatine—Somnolence—Niacin—atherosclerosis	0.00126	0.00381	CcSEcCtD
Agomelatine—Paraesthesia—Pravastatin—atherosclerosis	0.00125	0.00379	CcSEcCtD
Agomelatine—Dyspepsia—Niacin—atherosclerosis	0.00124	0.00378	CcSEcCtD
Agomelatine—Dyspepsia—Pravastatin—atherosclerosis	0.00122	0.00372	CcSEcCtD
Agomelatine—Urticaria—Simvastatin—atherosclerosis	0.00122	0.00371	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00122	0.0037	CcSEcCtD
Agomelatine—Abdominal pain—Simvastatin—atherosclerosis	0.00122	0.00369	CcSEcCtD
Agomelatine—Headache—Rosuvastatin—atherosclerosis	0.00122	0.00369	CcSEcCtD
Agomelatine—Fatigue—Pravastatin—atherosclerosis	0.0012	0.00364	CcSEcCtD
Agomelatine—Constipation—Pravastatin—atherosclerosis	0.00119	0.00361	CcSEcCtD
Agomelatine—Asthenia—Lovastatin—atherosclerosis	0.00118	0.00358	CcSEcCtD
Agomelatine—Pruritus—Lovastatin—atherosclerosis	0.00116	0.00353	CcSEcCtD
Agomelatine—Melatonin—MPO—atherosclerosis	0.00116	0.0687	CrCbGaD
Agomelatine—Asthenia—Ezetimibe—atherosclerosis	0.00116	0.00352	CcSEcCtD
Agomelatine—Gastrointestinal pain—Niacin—atherosclerosis	0.00115	0.00351	CcSEcCtD
Agomelatine—Nausea—Rosuvastatin—atherosclerosis	0.00115	0.0035	CcSEcCtD
Agomelatine—Pruritus—Ezetimibe—atherosclerosis	0.00114	0.00347	CcSEcCtD
Agomelatine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00114	0.00345	CcSEcCtD
Agomelatine—Diarrhoea—Lovastatin—atherosclerosis	0.00113	0.00342	CcSEcCtD
Agomelatine—Urticaria—Niacin—atherosclerosis	0.00112	0.00341	CcSEcCtD
Agomelatine—Abdominal pain—Niacin—atherosclerosis	0.00112	0.00339	CcSEcCtD
Agomelatine—Urticaria—Pravastatin—atherosclerosis	0.0011	0.00336	CcSEcCtD
Agomelatine—Asthenia—Simvastatin—atherosclerosis	0.0011	0.00335	CcSEcCtD
Agomelatine—Diarrhoea—Ezetimibe—atherosclerosis	0.0011	0.00335	CcSEcCtD
Agomelatine—Abdominal pain—Pravastatin—atherosclerosis	0.0011	0.00334	CcSEcCtD
Agomelatine—Nabumetone—PTGS2—atherosclerosis	0.00109	0.0647	CrCbGaD
Agomelatine—Pruritus—Simvastatin—atherosclerosis	0.00109	0.00331	CcSEcCtD
Agomelatine—Dizziness—Lovastatin—atherosclerosis	0.00109	0.0033	CcSEcCtD
Agomelatine—Dizziness—Ezetimibe—atherosclerosis	0.00107	0.00324	CcSEcCtD
Agomelatine—Diarrhoea—Simvastatin—atherosclerosis	0.00105	0.0032	CcSEcCtD
Agomelatine—Vomiting—Lovastatin—atherosclerosis	0.00105	0.00318	CcSEcCtD
Agomelatine—Headache—Lovastatin—atherosclerosis	0.00103	0.00313	CcSEcCtD
Agomelatine—Vomiting—Ezetimibe—atherosclerosis	0.00103	0.00312	CcSEcCtD
Agomelatine—Dizziness—Simvastatin—atherosclerosis	0.00102	0.00309	CcSEcCtD
Agomelatine—Asthenia—Niacin—atherosclerosis	0.00101	0.00308	CcSEcCtD
Agomelatine—Headache—Ezetimibe—atherosclerosis	0.00101	0.00307	CcSEcCtD
Agomelatine—Pruritus—Niacin—atherosclerosis	0.000999	0.00304	CcSEcCtD
Agomelatine—Asthenia—Pravastatin—atherosclerosis	0.000998	0.00303	CcSEcCtD
Agomelatine—Pruritus—Pravastatin—atherosclerosis	0.000984	0.00299	CcSEcCtD
Agomelatine—Vomiting—Simvastatin—atherosclerosis	0.000978	0.00297	CcSEcCtD
Agomelatine—Nausea—Lovastatin—atherosclerosis	0.000977	0.00297	CcSEcCtD
Agomelatine—Indomethacin—PPARG—atherosclerosis	0.000968	0.0574	CrCbGaD
Agomelatine—Diarrhoea—Niacin—atherosclerosis	0.000966	0.00294	CcSEcCtD
Agomelatine—Headache—Simvastatin—atherosclerosis	0.000964	0.00293	CcSEcCtD
Agomelatine—Nausea—Ezetimibe—atherosclerosis	0.000958	0.00291	CcSEcCtD
Agomelatine—Diarrhoea—Pravastatin—atherosclerosis	0.000951	0.00289	CcSEcCtD
Agomelatine—Dizziness—Niacin—atherosclerosis	0.000934	0.00284	CcSEcCtD
Agomelatine—Dizziness—Pravastatin—atherosclerosis	0.00092	0.00279	CcSEcCtD
Agomelatine—Nausea—Simvastatin—atherosclerosis	0.000914	0.00278	CcSEcCtD
Agomelatine—Vomiting—Niacin—atherosclerosis	0.000898	0.00273	CcSEcCtD
Agomelatine—Headache—Niacin—atherosclerosis	0.000885	0.00269	CcSEcCtD
Agomelatine—Vomiting—Pravastatin—atherosclerosis	0.000884	0.00269	CcSEcCtD
Agomelatine—Headache—Pravastatin—atherosclerosis	0.000871	0.00265	CcSEcCtD
Agomelatine—Melatonin—ESR1—atherosclerosis	0.000868	0.0515	CrCbGaD
Agomelatine—Nausea—Niacin—atherosclerosis	0.000839	0.00255	CcSEcCtD
Agomelatine—Nausea—Pravastatin—atherosclerosis	0.000826	0.00251	CcSEcCtD
Agomelatine—Naproxen—PTGS2—atherosclerosis	0.000504	0.0299	CrCbGaD
Agomelatine—Naproxen—ALB—atherosclerosis	0.000449	0.0266	CrCbGaD
Agomelatine—Indomethacin—PTGS2—atherosclerosis	0.000408	0.0242	CrCbGaD
Agomelatine—Indomethacin—ALB—atherosclerosis	0.000364	0.0216	CrCbGaD
Agomelatine—HTR2C—Signaling by GPCR—MMP3—atherosclerosis	5.96e-05	0.000226	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	5.95e-05	0.000226	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—F2—atherosclerosis	5.93e-05	0.000225	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PRKCG—atherosclerosis	5.89e-05	0.000224	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LTA4H—atherosclerosis	5.83e-05	0.000222	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCG8—atherosclerosis	5.83e-05	0.000222	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGT—atherosclerosis	5.83e-05	0.000222	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.76e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR2—atherosclerosis	5.76e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDNRA—atherosclerosis	5.76e-05	0.000219	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CYBA—atherosclerosis	5.73e-05	0.000218	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—PIK3CG—atherosclerosis	5.68e-05	0.000216	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.67e-05	0.000216	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EDN1—atherosclerosis	5.67e-05	0.000215	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—VEGFA—atherosclerosis	5.64e-05	0.000214	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—VEGFA—atherosclerosis	5.64e-05	0.000214	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL5—atherosclerosis	5.62e-05	0.000214	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PARP1—atherosclerosis	5.61e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLAT—atherosclerosis	5.61e-05	0.000213	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GHRL—atherosclerosis	5.61e-05	0.000213	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT3—atherosclerosis	5.59e-05	0.000212	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—STAT3—atherosclerosis	5.59e-05	0.000212	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.44e-05	0.000207	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCG1—atherosclerosis	5.4e-05	0.000205	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—F2—atherosclerosis	5.39e-05	0.000205	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PRKCG—atherosclerosis	5.35e-05	0.000203	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK3—atherosclerosis	5.34e-05	0.000203	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK3—atherosclerosis	5.34e-05	0.000203	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VWF—atherosclerosis	5.32e-05	0.000202	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOC3—atherosclerosis	5.29e-05	0.000201	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LDLR—atherosclerosis	5.26e-05	0.0002	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGT—atherosclerosis	5.18e-05	0.000197	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—atherosclerosis	5.18e-05	0.000197	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—atherosclerosis	5.18e-05	0.000197	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PIK3CG—atherosclerosis	5.16e-05	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL3—atherosclerosis	5.14e-05	0.000195	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LCAT—atherosclerosis	5.07e-05	0.000193	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FABP4—atherosclerosis	5.07e-05	0.000193	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA4—atherosclerosis	4.98e-05	0.000189	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KNG1—atherosclerosis	4.92e-05	0.000187	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NCF1—atherosclerosis	4.92e-05	0.000187	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR1—atherosclerosis	4.9e-05	0.000186	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP7A1—atherosclerosis	4.89e-05	0.000186	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.85e-05	0.000184	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL2—atherosclerosis	4.8e-05	0.000183	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—F2—atherosclerosis	4.79e-05	0.000182	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PLG—atherosclerosis	4.77e-05	0.000181	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGT—atherosclerosis	4.7e-05	0.000179	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.66e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR2—atherosclerosis	4.64e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDNRA—atherosclerosis	4.64e-05	0.000177	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CYBA—atherosclerosis	4.62e-05	0.000176	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCG1—atherosclerosis	4.61e-05	0.000175	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PIK3CG—atherosclerosis	4.58e-05	0.000174	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GHRL—atherosclerosis	4.53e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PARP1—atherosclerosis	4.53e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLAT—atherosclerosis	4.53e-05	0.000172	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP27A1—atherosclerosis	4.52e-05	0.000172	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SOCS3—atherosclerosis	4.52e-05	0.000172	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.45e-05	0.000169	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP3—atherosclerosis	4.36e-05	0.000166	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—F2—atherosclerosis	4.35e-05	0.000165	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF2—atherosclerosis	4.34e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.34e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FABP4—atherosclerosis	4.34e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LCAT—atherosclerosis	4.34e-05	0.000165	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA2—atherosclerosis	4.29e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALOX15—atherosclerosis	4.29e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	4.29e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	4.29e-05	0.000163	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA4—atherosclerosis	4.26e-05	0.000162	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCG5—atherosclerosis	4.23e-05	0.000161	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.23e-05	0.000161	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOB—atherosclerosis	4.22e-05	0.00016	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—atherosclerosis	4.18e-05	0.000159	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP7A1—atherosclerosis	4.18e-05	0.000159	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PIK3CG—atherosclerosis	4.16e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—atherosclerosis	4.15e-05	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL5—atherosclerosis	4.12e-05	0.000156	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPA—atherosclerosis	4.09e-05	0.000155	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LPL—atherosclerosis	4.03e-05	0.000153	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.98e-05	0.000151	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KNG1—atherosclerosis	3.97e-05	0.000151	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—BGN—atherosclerosis	3.96e-05	0.000151	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR1—atherosclerosis	3.95e-05	0.00015	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.93e-05	0.000149	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA5—atherosclerosis	3.92e-05	0.000149	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PRKCG—atherosclerosis	3.92e-05	0.000149	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—atherosclerosis	3.9e-05	0.000148	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—atherosclerosis	3.9e-05	0.000148	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL2—atherosclerosis	3.87e-05	0.000147	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP27A1—atherosclerosis	3.86e-05	0.000147	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PLG—atherosclerosis	3.85e-05	0.000146	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—atherosclerosis	3.81e-05	0.000145	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.81e-05	0.000145	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.8e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—atherosclerosis	3.8e-05	0.000144	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.77e-05	0.000143	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.73e-05	0.000142	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.71e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.7e-05	0.000141	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.69e-05	0.00014	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	3.66e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA2—atherosclerosis	3.66e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	3.66e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALOX15—atherosclerosis	3.66e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.65e-05	0.000139	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	3.64e-05	0.000139	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCG5—atherosclerosis	3.62e-05	0.000138	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.61e-05	0.000137	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AKT1—atherosclerosis	3.6e-05	0.000137	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AKT1—atherosclerosis	3.6e-05	0.000137	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDGFB—atherosclerosis	3.53e-05	0.000134	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP3—atherosclerosis	3.52e-05	0.000134	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—atherosclerosis	3.5e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPA—atherosclerosis	3.49e-05	0.000133	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—atherosclerosis	3.44e-05	0.000131	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOB—atherosclerosis	3.4e-05	0.000129	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—BGN—atherosclerosis	3.38e-05	0.000129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LEP—atherosclerosis	3.38e-05	0.000128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—atherosclerosis	3.38e-05	0.000128	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	3.37e-05	0.000128	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.37e-05	0.000128	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.36e-05	0.000128	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA5—atherosclerosis	3.35e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—atherosclerosis	3.35e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CAV1—atherosclerosis	3.34e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOA1—atherosclerosis	3.34e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	3.32e-05	0.000126	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.27e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.25e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.25e-05	0.000124	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LIPC—atherosclerosis	3.25e-05	0.000123	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—atherosclerosis	3.25e-05	0.000123	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOC3—atherosclerosis	3.23e-05	0.000123	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	3.23e-05	0.000123	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ESR1—atherosclerosis	3.22e-05	0.000122	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LDLR—atherosclerosis	3.21e-05	0.000122	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.19e-05	0.000121	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—F2—atherosclerosis	3.18e-05	0.000121	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.16e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	3.16e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.15e-05	0.00012	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CETP—atherosclerosis	3.13e-05	0.000119	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALOX5—atherosclerosis	3.12e-05	0.000118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	3.08e-05	0.000117	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	3.06e-05	0.000116	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PIK3CG—atherosclerosis	3.05e-05	0.000116	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—SCARB1—atherosclerosis	3e-05	0.000114	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.92e-05	0.000111	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—MAPK3—atherosclerosis	2.92e-05	0.000111	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—atherosclerosis	2.88e-05	0.00011	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.88e-05	0.000109	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	2.85e-05	0.000108	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL2—atherosclerosis	2.84e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.83e-05	0.000108	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.79e-05	0.000106	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1—atherosclerosis	2.79e-05	0.000106	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—atherosclerosis	2.78e-05	0.000106	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.78e-05	0.000106	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LIPC—atherosclerosis	2.78e-05	0.000106	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOC3—atherosclerosis	2.76e-05	0.000105	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LDLR—atherosclerosis	2.74e-05	0.000104	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LEP—atherosclerosis	2.72e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—atherosclerosis	2.72e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	2.7e-05	0.000103	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	2.69e-05	0.000102	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CETP—atherosclerosis	2.68e-05	0.000102	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—atherosclerosis	2.65e-05	0.000101	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	2.6e-05	9.88e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—F2—atherosclerosis	2.57e-05	9.76e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—SCARB1—atherosclerosis	2.57e-05	9.75e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.56e-05	9.72e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NOS3—atherosclerosis	2.53e-05	9.61e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.53e-05	9.6e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.5e-05	9.49e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	2.46e-05	9.34e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMGCR—atherosclerosis	2.42e-05	9.21e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	2.35e-05	8.94e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—atherosclerosis	2.33e-05	8.84e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	2.29e-05	8.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	2.25e-05	8.55e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—atherosclerosis	2.24e-05	8.52e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.19e-05	8.3e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.17e-05	8.24e-05	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AKT1—atherosclerosis	2.17e-05	8.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.16e-05	8.21e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	2.14e-05	8.12e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—atherosclerosis	2.13e-05	8.11e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOB—atherosclerosis	2.08e-05	7.89e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	2.04e-05	7.75e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—atherosclerosis	2.03e-05	7.71e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.02e-05	7.68e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	2.01e-05	7.63e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—atherosclerosis	1.98e-05	7.53e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	1.97e-05	7.5e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	1.97e-05	7.48e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—atherosclerosis	1.93e-05	7.35e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CD36—atherosclerosis	1.88e-05	7.16e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.85e-05	7.04e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	1.82e-05	6.92e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	1.81e-05	6.88e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT3—atherosclerosis	1.8e-05	6.85e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.79e-05	6.78e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOB—atherosclerosis	1.77e-05	6.74e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARA—atherosclerosis	1.75e-05	6.66e-05	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	1.75e-05	6.64e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.73e-05	6.56e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	1.72e-05	6.55e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	1.72e-05	6.54e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—atherosclerosis	1.7e-05	6.45e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—atherosclerosis	1.69e-05	6.44e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	1.67e-05	6.35e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—atherosclerosis	1.66e-05	6.32e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—atherosclerosis	1.65e-05	6.28e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CAV1—atherosclerosis	1.65e-05	6.26e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOA1—atherosclerosis	1.64e-05	6.24e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	1.64e-05	6.22e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	1.62e-05	6.15e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CD36—atherosclerosis	1.61e-05	6.12e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	1.59e-05	6.05e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	1.59e-05	6.03e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.53e-05	5.8e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.5e-05	5.7e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARA—atherosclerosis	1.5e-05	5.69e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	1.47e-05	5.59e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	1.46e-05	5.53e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—atherosclerosis	1.45e-05	5.51e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARG—atherosclerosis	1.45e-05	5.5e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—atherosclerosis	1.42e-05	5.4e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—atherosclerosis	1.42e-05	5.4e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CAV1—atherosclerosis	1.41e-05	5.35e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOA1—atherosclerosis	1.4e-05	5.34e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	1.39e-05	5.28e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	1.35e-05	5.13e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—atherosclerosis	1.3e-05	4.95e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.28e-05	4.87e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—atherosclerosis	1.26e-05	4.79e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NOS3—atherosclerosis	1.25e-05	4.73e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARG—atherosclerosis	1.24e-05	4.7e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—atherosclerosis	1.21e-05	4.61e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AKT1—atherosclerosis	1.16e-05	4.42e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.14e-05	4.33e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—atherosclerosis	1.11e-05	4.23e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NOS3—atherosclerosis	1.06e-05	4.04e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—atherosclerosis	1.02e-05	3.86e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PTGS2—atherosclerosis	9.73e-06	3.7e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	9.38e-06	3.56e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AKT1—atherosclerosis	5.72e-06	2.17e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AKT1—atherosclerosis	4.89e-06	1.86e-05	CbGpPWpGaD
